This can create inequality in access
E.et al (2022)
It's a complementary mechanism, not a replacement for established therapies the strongest protocols combine multiple approaches
To achieve equivalent systemic levels, nasal spray users need to administer proportionally higher doses
Some may notice mild, temporary redness or irritation at the injection site, with occasional stinging upon administration
Yang De, Chen Q, Schmidt AP et al (2000) LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells